- Home
- PLBC vs SOPH Comparison
PLBC vs SOPH Comparison
Compare PLBC & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLBC | SOPH |
|---|---|---|
| Founded | 1980 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.9M | 367.7M |
| IPO Year | 2002 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLBC | SOPH |
|---|---|---|
| Price | $48.49 | $4.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $55.50 | $7.00 |
| AVG Volume (30 Days) | 29.9K | ★ 107.1K |
| Earning Date | 04-22-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.73% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.94 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.59 | $16.16 |
| Revenue Next Year | $5.15 | $17.56 |
| P/E Ratio | $16.48 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.71 | $2.58 |
| 52 Week High | $54.58 | $5.70 |
Technical Indicators
Market Signals| Indicator | PLBC | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 36.51 | 50.53 |
| Support Level | $40.95 | $4.54 |
| Resistance Level | $49.24 | $4.86 |
| Average True Range (ATR) | 1.35 | 0.29 |
| MACD | -0.48 | 0.03 |
| Stochastic Oscillator | 10.18 | 72.57 |
Price Performance
Historical ComparisonAbout PLBC Plumas Bancorp
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.